Skip to megamenu (after main content)
Meet us next:   BIO International Convention 2025 – 4 September  ●  The Cell & Gene Meeting on the Mesa 2025 – 6-8 October (in person) & 9-10 October (virtual)  ●  more on our events calendar
Prices for NutriStem, NutriCoat, and NutriFreez products will increase effective 1st August. Lock in the current price by getting your order by 31st July.

Recombinant human IL-4 protein

QK092

Brand: Qkine

Interleukin-4 (IL-4) is a pleiotropic, immune-modulatory cytokine that is secreted primarily by mast cells, T-cells, eosinophils, and basophils. IL-4 plays a crucial role in hematopoiesis, the regulation of antibody production, the stimulation of activated B cell and T cell proliferation, and the differentiation of B cells into plasma cells

Human IL-4 has a molecular weight of 15.1 kDa. This protein is animal origin-free, carrier-free and tag-free to ensure its purity with exceptional lot-to-lot consistency. Qk092 is suitable for the culture of reproducible and high-quality stem cells and other relevant cells.

Currency: 

Product name Catalog number Pack size Price Price (USD) Price (GBP) Price (EUR)
Recombinant human IL-4 protein, 25 µg QK092-0025 25 µg (select above) $ 280.00 £ 205.00 € 240.00
Recombinant human IL-4 protein, 50 µg QK092-0050 50 µg (select above) $ 410.00 £ 305.00 € 357.00
Recombinant human IL-4 protein, 100 µg QK092-0100 100 µg (select above) $ 620.00 £ 455.00 € 532.00
Recombinant human IL-4 protein, 500 µg QK092-0500 500 µg (select above) $ 2,500.00 £ 1,840.00 € 2,150.00
Recombinant human IL-4 protein, 1000 µg QK092-1000 1000 µg (select above) $ 3,950.00 £ 2,900.00 € 3,388.00

Note: prices shown do not include shipping and handling charges.

Qkine company name and logo are the property of Qkine Ltd. UK.

Alternative protein names
Interleukin-4
B-cell stimulatory factor 1 (BSF-1)
Binetrakin
Lymphocyte stimulatory factor 1
Pitrakinra
Species reactivity

human

species similarity:
mouse – 39%
rat – 38%
porcine – 59%
bovine – 55%


Summary

  • High purity human IL-4 protein (Uniprot number: P05112)
  • 15.1 kDa (monomer)
  • >98%, by SDS-PAGE quantitative densitometry
  • Expressed in E. coli
  • Animal origin-free (AOF) and carrier protein-free
  • Manufactured in our Cambridge, UK laboratories
  • Lyophilized from acetonitrile, TFA
  • Resuspend in sterile-filtered water at >50 µg/ml, add carrier protein if desired, prepare single use aliquots and store frozen at -20 °C (short-term) or -80 °C (long-term).
Handling and Storage FAQ

Featured applications

  • Stimulation of activated T cell proliferation
  • Stimulation of activated B cell proliferation
  • Differentiation of B cells into plasma cells
  • Lymphoid differentiation

Bioactivity

IL-4 activity is determined using proliferation of TF-1 human myeloid leukemia cells. EC50 = 235 pg/mL (16 pM). Cells are treated in triplicate with a serial dilution of IL-4 for 72 hours. Cell viability is measured using the CellTiter-Glo (Promega) luminescence assay. Data from Qk092 lot #204598. 

Qk092-IL-4-Datasheet-graph_-Data

Purity

Recombinant IL-4 migrates as a major band at approximately 14 kDa in non-reducing (NR) and at approximately 12.5 kDa in reduced (R) conditions. No contaminating protein bands are present. The purified recombinant protein (3 µg) was resolved using 15% w/v SDS-PAGE in reduced (+β-mercaptoethanol, R) and non-reduced conditions and stained with Coomassie Brilliant Blue R250. Data from Qk092 batch #204598. 

IL-4-Gel-web-600px

Further quality assays

  • Mass spectrometry, single species with the expected mass
  • Endotoxin: <0.005 EU/μg protein (below the level of detection)
  • Recovery from stock vial: >95%

Qk092-IL-4-Datasheet-graph_-Comparison

Qkine IL-4 is as biologically active as a comparable alternative supplier protein. Stimulation of proliferation of TF-1 cells with Qkine IL-4 (Qk092, green) and alternative supplier IL-4 (Supplier B, black). Cells were treated in triplicate with a serial dilution of IL-4 for 72 hours and proliferation measured using the CellTiter-Glo (Promega) luminescence assay.


Protein background

Interleukin 4 (IL-4) is an important signaling molecule within the immune system, playing multiple roles in orchestrating immune responses and maintaining immune homeostasis. IL-4 is primarily produced by immune cells, including mast cells, T helper 2 (Th2) cells, eosinophils, and basophils, and exerts its effects through interaction with its specific receptor, IL-4Rα and subsequent activation of downstream signaling pathways [1]. IL-4 plays a crucial role in hematopoiesis, the regulation of antibody production, the stimulation of activated B cell and T cell proliferation, and the differentiation of B cells into plasma cells. IL-4 induces the expression of class II MHC molecules on resting B-cells and aids regulation of the low-affinity Fc receptor for IgE (CD23) expression on lymphocytes and monocytes [2].

IL-4 has a compact, globular fold stabilized by three disulfide bonds. IL-4 consists of a characteristic four-alpha helix bundle with a left-handed twist, along with a two-stranded anti-parallel beta-sheet [2]. This structural arrangement allows stability to IL-4 and also facilitates its interaction with its receptor, IL-4Rα. The receptor for IL-4, IL-4Rα, exists in three distinct complexes within the body, each playing a crucial role in mediating IL-4 signaling [3]. Type 1 receptors consist of the IL-4Rα subunit coupled with a common gamma chain, while type 2 receptors comprise the IL-4Rα subunit bound to IL-13Rα1. Type 1 receptors specifically bind IL-4, whereas type 2 receptors have the capacity to bind both IL-4 and IL-13, two cytokines with closely related functions. This differential receptor composition allows for nuanced regulation of immune responses depending on the specific ligands present [4].

IL-4 serves as a regulator of immune cell differentiation and activation [5]. It promotes the differentiation of naive T cells into Th2 cells, which are crucial for orchestrating immune responses against extracellular pathogens and for mediating allergic reactions. Additionally, IL-4 stimulates the proliferation and activation of B cells, leading to the production of antibodies and the formation of memory B cells [6]. IL-4 plays a pivotal role in modulating macrophage polarization and the development of an alternative activation phenotype (M2) associated with tissue repair and resolution of inflammation [7].

In the context of disease, dysregulation of IL-4 signaling has been implicated in various immune disorders, including allergies, asthma, and autoimmune diseases. Enhanced IL-4 production or aberrant IL-4 receptor signaling can contribute to the pathogenesis of allergic inflammation and tissue damage. Therapeutic strategies aimed at targeting IL-4 or its receptor have shown promise in treating these conditions by modulating immune responses and dampening inflammation [8].

Background references

  1. Paul, W. E. Interleukin 4: a prototypic immunoregulatory lymphokine. Blood 77, 1859–1870 (1991). PMID: 2018830
  2. Gadani, S. P., Cronk, J. C., Norris, G. T., & Kipnis, J. IL-4 in the brain: a cytokine to remember. Journal of Immunology 189, 4213–4219 (2012). doi: 10.4049/jimmunol.1202246
  3. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E. The IL-4 receptor: signaling mechanisms and biologic functions. Annual Review of Immunology 17, 701–738 (1999). doi: 10.1146/annurev.immunol.17.1.701
  4. Ul-Haq, Z., Naz, S., & Mesaik, M. A. Interleukin-4 receptor signaling and its binding mechanism: A therapeutic insight from inhibitors tool box. Cytokine & Growth Factor Reviews 32, 3–15 (2016). doi: 10.1016/j.cytogfr.2016.04.002
  5. Gordon, S., & Martinez, F. O. Alternative activation of macrophages: mechanism and functions. Immunity 32, 593–604 (2010). doi: 10.1016/j.immuni.2010.05.007.
  6. Bhattarai, P et al. IL4/STAT6 Signaling Activates Neural Stem Cell Proliferation and Neurogenesis upon Amyloid-β42 Aggregation in Adult Zebrafish Brain. Cell Reports 17, 941–948 (2016). doi: 10.1016/j.celrep.2016.09.075
  7. Hershey, G. K. IL-13 receptors and signaling pathways: an evolving web. Journal of Allergy and Clinical Immunology 111, 677–690 (2003). doi: 10.1067/mai.2003.1333
  8. Chatila, T. A. Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends in Molecular Medicine 10, 493–499 (2004). doi: 10.1016/j.molmed.2004.08.004